Methyl 1-Boc-piperidine-2-carboxylate, 95.0%, 100g

Ethyl 7-nitro-1H-indole-2-carboxylate, 95.0%, 500g

6-Chloro-5-(trifluoromethyl)pyridin-3-ol, 97.0%, 5g

5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylic acid, 95.0%, 25g

2-Fluoro-4-methoxy-1-(trifluoromethyl)benzene, 95.0%, 5g

Naphthalene-2,6-diyl diacetate, 95.0%, 5g

4-(4-bromobenzoyl)-8-ethyl-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

N-(cyanomethyl)-4-methylbenzenesulfonamide, 97%, 5g

(S)-(9H-Fluoren-9-yl)methyl (1-oxo-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentan-2-yl)carbamate, 98%, 1g

(R)-Methyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-mercaptopropanoate, 98%, 500mg

Coomassie Brilliant Blue G-250 (Ready-to-use solution) [for Electrophoresis]500mL

2,5-Bis(2-ethylhexyl)-3,6-bis(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione, 95%, 100mg

4-Hydroxy-4-[5-(pyrimidin-2-yl)pyridin-2-yl]cyclohexan-1-one, 98%, 10g